 |
Previous Article | Next Article 
The Journal of Neuroscience, November 1, 2002, 22(21):9378-9386
Identification of the Neuroprotective Molecular Region of Pigment
Epithelium-Derived Factor and Its Binding Sites on Motor Neurons
Masako M.
Bilak1,
S.
Patricia
Becerra2,
Andrea M.
Vincent3,
Brian H.
Moss1,
Maria S.
Aymerich2, and
Ralph W.
Kuncl4
1 Department of Neurology, Johns Hopkins University
School of Medicine, Baltimore, Maryland 21287, 2 National Eye Institute, National Institutes of Health,
Bethesda, Maryland 20892, 3 Department of Neurology,
University of Michigan, Ann Arbor, Michigan 48109, and
4 Department of Biology, Bryn Mawr College, Bryn Mawr,
Pennsylvania 19010
Pigment epithelium-derived factor (PEDF), a member of the serine
protease inhibitor (serpin) family, is a survival factor for various
types of neurons. We studied the mechanisms by which human PEDF
protects motor neurons from degeneration, with the goal of eventually
conducting human clinical trials. We first searched for a molecular
region of human PEDF essential to motor neuron protection. Using a
spinal cord culture model of chronic glutamate toxicity, we show herein
that a synthetic 44 mer peptide from an N-terminal region of the human
PEDF molecule that lacks the homologous serpin-reactive region contains
its full neuroprotective activity. We also investigated the presence
and distribution of PEDF receptors in the spinal cord. Using a
fluoresceinated PEDF probe, we show that spinal motor neurons contain
specific binding sites for PEDF. Kinetics analyses using a radiolabeled
PEDF probe demonstrate that purified rat motor neurons contain a single
class of saturable and specific binding sites. This study indicates that a small peptide fragment of the human PEDF molecule could be
engineered to contain all of its motor neuron protective activity, and
that the neuroprotective action is likely to be mediated directly on
motor neurons via a single class of PEDF receptors. The data support
the pharmacotherapeutic potential of PEDF as a neuroprotectant in human
motor neuron degeneration.
Key words:
amyotrophic lateral sclerosis; motor neurons; neurodegeneration; neuroprotection; neurotrophic factor; peptide; pigment epithelium-derived factor; serpin; spinal cord
Copyright © 2002 Society for Neuroscience 0270-6474/02/22219378-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
A. Bernard, J. Gao-Li, C.-A. Franco, T. Bouceba, A. Huet, and Z. Li
Laminin Receptor Involvement in the Anti-angiogenic Activity of Pigment Epithelium-derived Factor
J. Biol. Chem.,
April 17, 2009;
284(16):
10480 - 10490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Notari, V. Baladron, J. D. Aroca-Aguilar, N. Balko, R. Heredia, C. Meyer, P. M. Notario, S. Saravanamuthu, M.-L. Nueda, F. Sanchez-Sanchez, et al.
Identification of a Lipase-linked Cell Membrane Receptor for Pigment Epithelium-derived Factor
J. Biol. Chem.,
December 8, 2006;
281(49):
38022 - 38037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. T.H. Ek, C. R. Dass, and P. F.M. Choong
Pigment epithelium-derived factor: a multimodal tumor inhibitor.
Mol. Cancer Ther.,
July 1, 2006;
5(7):
1641 - 1646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hase, M. Miyamoto, H. Uehara, M. Kadoya, Y. Ebihara, Y. Murakami, R. Takahashi, S. Mega, L. Li, T. Shichinohe, et al.
Pigment Epithelium-Derived Factor Gene Therapy Inhibits Human Pancreatic Cancer in Mice
Clin. Cancer Res.,
December 15, 2005;
11(24):
8737 - 8744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Amaral, R. N. Fariss, M. M. Campos, W. G. Robison Jr, H. Kim, R. Lutz, and S. P. Becerra
Transscleral-RPE Permeability of PEDF and Ovalbumin Proteins: Implications for Subconjunctival Protein Delivery
Invest. Ophthalmol. Vis. Sci.,
December 1, 2005;
46(12):
4383 - 4392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Filleur, K. Volz, T. Nelius, Y. Mirochnik, H. Huang, T. A. Zaichuk, M. S. Aymerich, S. P. Becerra, R. Yap, D. Veliceasa, et al.
Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer
Cancer Res.,
June 15, 2005;
65(12):
5144 - 5152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Lopez-Coviella, M. T. Follettie, T. J. Mellott, V. P. Kovacheva, B. E. Slack, V. Diesl, B. Berse, R. S. Thies, and J. K. Blusztajn
Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons
PNAS,
May 10, 2005;
102(19):
6984 - 6989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Garcia, N. I. Fernandez-Garcia, V. Rivas, M. Carretero, M. J. Escamez, A. Gonzalez-Martin, E. E. Medrano, O. Volpert, J. L. Jorcano, B. Jimenez, et al.
Inhibition of Xenografted Human Melanoma Growth and Prevention of Metastasis Development by Dual Antiangiogenic/Antitumor Activities of Pigment Epithelium-Derived Factor
Cancer Res.,
August 15, 2004;
64(16):
5632 - 5642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu, J.-G. Ren, W. L. Cooper, C. E. Hawkins, M. R. Cowan, and P. Y. Tong
Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site
PNAS,
April 27, 2004;
101(17):
6605 - 6610.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|